Latest Articles

Publication Date
Engineering Anti-MMP-9 Peptide-Modified Nanoparticles for Precision MRI Diagnosis of Endometriosis.

Endometriosis diagnosis is often limited by the resolution of conventional imaging techniques (ultrasound/non-targeted MRI) as well as the invasiveness and recurrence risks associated with laparoscopy. To overcome these challenges, we …

Published: Feb. 27, 2026, midnight
Chloe Scharffenberg’s Endometriosis Story Is Still Being Written as She Battles The Disease’s Recurrence - Endometriosis Foundation of America

Chloe Scharffenberg’s Endometriosis Story Is Still Being Written as She Battles The Disease’s Recurrence Endometriosis Foundation of America

Published: Feb. 26, 2026, 8:26 p.m.
Dynamics of diaphragmatic endometriosis with thoracic endometriosis-related pneumothorax.

Pneumothorax that occurs during menstruation is called catamenial pneumothorax; however, it is also called thoracic endometriosis-related pneumothorax (TERP) because of its etiology. Because of its high postoperative recurrence rate, TERP …

Published: Feb. 25, 2026, midnight
Percutaneous Cryoablation for the Management of Bone and Soft Tissue Tumors.

Image-guided percutaneous cryoablation plays an increasingly important role in managing bone and soft tissue tumors. Well-established indications include the treatment of osteoid osteoma, palliation of painful skeletal metastases, and local …

Published: Feb. 20, 2026, midnight
Central sensitization in women with endometriosis: a cross-sectional study.

Pain is the primary symptom of endometriosis and may progress into a chronic, acyclic condition driven by neuroinflammatory mechanisms, leading to neuropathic and ultimately nociplastic pain. Central sensitization, a form …

Published: Feb. 17, 2026, midnight
Dydrogesterone and Letrozole Combination for the Treatment of Endometriosis: A Mechanism-Based Therapeutic Approach.

Endometriosis is a complex, estrogen-dependent disease with limited effective treatments that often focus on symptom management rather than addressing the underlying pathology. Current therapies, such as progestins and GnRH agonists, …

Published: Feb. 13, 2026, midnight
Exploring the therapeutic potential of disulfiram in endometriosis: mechanisms targeting inflammation, oxidative stress, pyroptosis, and angiogenesis.

Endometriosis (EMS) is a prevalent, inflammatory gynecological disorder with limited effective treatments and high recurrence rates. Given the central roles of inflammation, oxidative stress, pyroptosis, and angiogenesis in its pathogenesis, …

Published: Feb. 12, 2026, midnight
2-Deoxyglucose dendrimer-enabled niclosamide delivery to FRβ-expressing macrophages alleviates endometriosis progression and associated hyperalgesia.

Endometriosis is a chronic, incurable disease. Due to limited efficacy, high recurrence rates, and serious side effects of current treatments, development of new, targeted, non-hormonal therapies is urgently needed. We …

Published: Feb. 12, 2026, midnight
Targeting HSP90 as a therapeutic approach for endometriosis: insights from proteomic analysis.

Endometriosis, a chronic inflammatory condition characterized by pain and infertility, remains a clinical challenge. Current hormonal and surgical treatments are often limited by side effects and high recurrence rates. In …

Published: Feb. 7, 2026, midnight
Therapeutic Effects of Vitamins in Endometriosis Patients: A Systematic Review of Randomized Controlled Trials.

Endometriosis is a chronic, estrogen-dependent inflammatory condition affecting approximately 10% of women of reproductive age worldwide. It is characterized by the presence of endometrial-like tissue outside the uterine cavity, which …

Published: Feb. 2, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!